GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
Not only do I use them under my eyes, but I also use them on my smile lines
A microdose usually means less than the 0.25 mg starter, often 0.1 to 0.2 mg weekly
Frontiers in immunology, 14, 1148209
ISF induced gastric and intestinal distension, which increased circulating GLP-1 levels and activated a subset of vagal sensory neurons (Fig